크립토코쿠스 수막염 : 일개 대학병원에서 최근 12년간의 경험
Cryptococcal Meningitis : 12 Years Experience in a Single Tertiary Health Care Center
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Cryptococcal infections are frequent in human immunodeficiency virus (HIV)-infected patients. This infection may occur in other immunocompromised patients, and the diagnosis is often delayed in these cases. There are a few reports on cryptococcal meningitis in non-HIV-infected patients in Korea. We reviewed the clinical features and efficacy of antifungal therapy in 33 patients who were treated at a single tertiary health care center of Korea. Materials and Methods: The medical records of 33 consecutive patients who were admitted to one tertiary hospital for cryptococcal meningitis between 1995 and 2008 were reviewed retrospectively. Cryptococcal meningitis was confirmed by positive cerebral spinal fluid (CSF) cultures or compatible clinical features plus a positive cryptococcal antigen test of CSF. Results: Of the 33 patients analyzed, 30 cases were non-HIV patients. The outcomes were complete cure in 23 cases, relapse after initial treatment in four cases, and death due to treatment failure in six cases. The main initial manifestations were headache (84.8%), fever (54.5%), and seizure (33.3%). Factors significantly associated with unfavorable outcomes, including mortality and relapse, were afebrile condition, mental change, hearing impairment, initial high opening pressure of CSF (>250 mmH2O), and low initial absolute neutrophil count. On multivariate analysis,afebrile condition was an independent predictor of an unfavorable outcome (odds ratio 17.3; 95% confidence interval 1.0-28.3; P=0.045). Conclusions: It is necessary to observe closely cryptococcal meningitis patients without fever on admission.
Abstract
Background: Cryptococcal infections are frequent in human immunodeficiency virus (HIV)-infected patients. This infection may occur in other immunocompromised patients, and the diagnosis is often delayed in these cases. There are a few reports on cryptococcal meningitis in non-HIV-infected patients in Korea. We reviewed the clinical features and efficacy of antifungal therapy in 33 patients who were treated at a single tertiary health care center of Korea. Materials and Methods: The medical records of 33 consecutive patients who were admitted to one tertiary hospital for cryptococcal meningitis between 1995 and 2008 were reviewed retrospectively. Cryptococcal meningitis was confirmed by positive cerebral spinal fluid (CSF) cultures or compatible clinical features plus a positive cryptococcal antigen test of CSF. Results: Of the 33 patients analyzed, 30 cases were non-HIV patients. The outcomes were complete cure in 23 cases, relapse after initial treatment in four cases, and death due to treatment failure in six cases. The main initial manifestations were headache (84.8%), fever (54.5%), and seizure (33.3%). Factors significantly associated with unfavorable outcomes, including mortality and relapse, were afebrile condition, mental change, hearing impairment, initial high opening pressure of CSF (>250 mmH2O), and low initial absolute neutrophil count. On multivariate analysis,afebrile condition was an independent predictor of an unfavorable outcome (odds ratio 17.3; 95% confidence interval 1.0-28.3; P=0.045). Conclusions: It is necessary to observe closely cryptococcal meningitis patients without fever on admission.
참고문헌 (28)
- Casadevall A, "Cryptococcus neoformans" (1998), ASM Press
- Jarvis JN, "HIV-associated cryptococcal meningitis", AIDS, 21, pp.2119~2129 (2007)
- Levitz SM, "The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis", Rev Infect Dis, 13, pp.1163~1169 (1991)
- Lee SC, "Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications", Hum Pathol, 27, pp.839~847 (1996)
- Butler WT, "Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis, a follow-up study of forty patients", N Engl J Med, 270, pp.59~67 (1964)
- Powderly WG, "A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome", N Engl J Med, 326, pp.793~798 (1992)
- van der Horst CM, "Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome", N Engl J Med, 337, pp.15~21 (1997)
- Perfect JR, "Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America", Clinl Infect Dis, 50, pp.291~322 (2010)
- Diamond RD, "Prognostic factors in cryptococcal meningitis. A study in 111 cases", Ann Intern Med, 80, pp.176~181 (1974)
- Kim JW, "Differentiation of varieties and susceptibility testing for two strains of Cryptococcus neoformans", Korean J Clin Pathol, 18, pp.550~553 (1998)
- Hee Youn Chee, "Isolation of Cryptococcus neoformans var. grubii (serotype A) from Pigeon Droppings in Seoul, Korea", The Journal of Microbiology, 43(5), pp.469~472 (2005), 한국미생물학회
- Duperval R, "Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract", Chest, 72, pp.13~19 (1977)
- Mitchell TG, "Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans", Clin Microbiol Rev, 8, pp.515~548 (1995)
- Rozenbaum R, "Clinical epidemiological study of 171 cases of cryptococcosis", Clin Infect Dis, 18, pp.369~380 (1994)
- Speed B, "Clinical and host differences between infections with the two varieties of Cryptococcus neoformans", Clin Infect Dis, 21, pp.28~34 (1995)
- Dismukes WE, "Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks", N Engl J Med, 317, pp.334~341 (1987)
- Chuang YM, "Disseminated cryptococcosis in HIV-uninfected patients", Eur J Clin Microbiol Infect Dis, 27, pp.307~310 (2008)
- Jean SS, "Cryptococcaemia: clinical features and prognostic factors", QJM, 95, pp.511~518 (2002)
- Berlin L, "Cryptococcal meningitis. False-negative antigen test results and cultures in nonimmunosuppressed patients", Arch Neurol, 46, pp.1312~1316 (1989)
- Won DI, "Clinical features of cryptococcosis patients and evaluation of the diagnostic tests", Korean J Infect Dis, 30, pp.61~68 (1998)
- Kaplan JE, "Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America", MMWR Recomm Rep, 58, pp.1~207 (2009)
- Graybill JR, "Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis", Clin Infect Dis, 30, pp.47~54 (2000)
- Fessler RD, "Management of elevated intracranial pressure in patients with Cryptococcal meningitis", J Acquir Immune Defic Syndr Hum Retrovirol, 17, pp.137~142 (1998)
- Dromer F, "Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases", Clin Infect Dis, 22(Suppl 2), pp.S154~S160 (1996)
- Tjia TL, "Cryptococcal meningitis", J Neurol Neurosurg Psychiatry, 48, pp.853~858 (1985)
- Chuck SL, "Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome", N Engl J Med, 321, pp.794~799 (1989)
- White M, "Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease", J Infect Dis, 165, pp.960~963 (1992)
- Mirza SA, "The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000", Clin Infect Dis, 36, pp.789~794 (2003)